223 related articles for article (PubMed ID: 9261742)
1. Responsiveness to recombinant human erythropoietin (rh-Epo) of marrow erythroid progenitors (CFU-E and BFU-E) from B-chronic lymphocytic leukemia (B-CLL).
Tsatalas C; Chalkia P; Tsantali C; Kakoulidis I; Garyfallos A; Klonizakis I; Panayiotopoulos S
J Exp Clin Cancer Res; 1997 Jun; 16(2):163-70. PubMed ID: 9261742
[TBL] [Abstract][Full Text] [Related]
2. Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin.
Aoki I; Taniyama M; Toyama K; Homori M; Ishikawa K
Stem Cells; 1994 May; 12(3):329-38. PubMed ID: 7521243
[TBL] [Abstract][Full Text] [Related]
3. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
4. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
[TBL] [Abstract][Full Text] [Related]
5. Erythroid progenitors in polycythemia vera demonstrate a different response pattern to IL-4 compared to the normal BFU-E from peripheral blood.
de Wolf JT; Hendriks DW; Beentjes JA; Esselink MT; Smit JW; Halie MR; Vellenga E
Exp Hematol; 1991 Oct; 19(9):888-92. PubMed ID: 1893965
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of recombinant human erythropoietin on bone marrow progenitor cells.
Jaar B; Baillou C; Viron B; Michel C; Mignon F; Najman A
Nephrol Dial Transplant; 1993; 8(7):614-20. PubMed ID: 8396745
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of bone marrow erythroid progenitors (CFU-E and BFU-E) to recombinant human erythropoietin (rh-Ep) in vitro in multiple myeloma.
Aoki I; Nishijima K; Homori M; Nakahara K; Higashi K; Ishikawa K
Br J Haematol; 1992 Aug; 81(4):463-9. PubMed ID: 1390230
[TBL] [Abstract][Full Text] [Related]
8. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
[TBL] [Abstract][Full Text] [Related]
9. [In vitro effects of high titers of recombinant human erythropoietin on the bone marrow erythroid progenitors in patients with aplastic anemia].
Aoki I; Chikazawa H; Higashi K; Ishikawa K
Rinsho Ketsueki; 1989 Apr; 30(4):437-42. PubMed ID: 2769966
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide.
Malgor LA; Valsecia M; Vergés E; De Markowsky EE
Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):99-105. PubMed ID: 9695882
[TBL] [Abstract][Full Text] [Related]
11. The sensitivity of in vitro erythropoietic progenitor cells to different erythropoietin reagents during development and the role of cell death in culture.
Zimmermann F; Rich IN
Exp Hematol; 1996 Feb; 24(2):330-9. PubMed ID: 8641362
[TBL] [Abstract][Full Text] [Related]
12. Effects of ubenimex on erythroid progenitors (CFU-E and BFU-E) in human bone marrow.
Aoki I; Higashi K; Nishijima K; Homori M; Chikazawa H; Ishikawa K
Exp Hematol; 1991 Oct; 19(9):893-8. PubMed ID: 1893966
[TBL] [Abstract][Full Text] [Related]
13. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes.
Merchav S; Nielsen OJ; Rosenbaum H; Sharon R; Brenner B; Tatarsky I; Scigalla P; Wieczorek L
Leukemia; 1990 Nov; 4(11):771-4. PubMed ID: 2232891
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin and chronic lymphocytic leukemia.
Mauro FR; Gentile M; Foa R
Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human erythroid colony-forming units by interferons alpha and beta: differing mechanisms despite shared receptor.
Means RT; Krantz SB
Exp Hematol; 1996 Feb; 24(2):204-8. PubMed ID: 8641342
[TBL] [Abstract][Full Text] [Related]
16. Ca++ and 1,25(OH)2D3 regulate in vitro and in vivo the response to human recombinant erythropoietin in CAPD patients.
Carozzi S; Ramello A; Nasini MG; Schelotto C; Caviglia PM; Cantaluppi A; Salit M; Lamperi S
Adv Perit Dial; 1990; 6():312-5. PubMed ID: 1982836
[TBL] [Abstract][Full Text] [Related]
17. Amifostine stimulates the formation of hematopoietic bone marrow progenitors from B-cell chronic lymphocytic leukemia.
Tsatalas C; Spanoudakis E; Pantelidou D; Margaritis D; Kotsianidis I; Chalkia P; Tripsianis G; Basdiara I; Kartasis Z; Karakolios A; Bourikas G
Acta Haematol; 2004; 112(3):136-40. PubMed ID: 15345895
[TBL] [Abstract][Full Text] [Related]
18. Canine BFU-e progenitors: adaptation of a reproducible assay and anatomical distribution.
Deldar A; Stevens CE; Rodocker KB
Int J Cell Cloning; 1991 Nov; 9(6):579-93. PubMed ID: 1770231
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
20. Responsiveness of bone marrow erythropoietic stem cells (CFU-E and BFU-E) to recombinant human erythropoietin (rh-Ep) in vitro in aplastic anemia and myelodysplastic syndrome.
Aoki I; Higashi K; Homori M; Chikazawa H; Ishikawa K
Am J Hematol; 1990 Sep; 35(1):6-12. PubMed ID: 2389770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
